It modulates inflammatory markers like NF-κB and cell cycle regulators such as Cyclin D and p53, while its tumor-suppressive effects are mediated through molecular markers like PCDH17 and SOX2 [13,23]. The gene discussed is NFKB1; the disease is neoplasm.